Lenograstim biosimilar (Biosidus)

来格司亭生物类似药 (Biosidus)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLenograstim biosimilar (Biosidus)

Drug Alias Name来格司亭生物仿制药 (Biosidus)LenobioLenograstim BiosidusLeumostin

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesBiosidus

China Registration ClassN/A

Active CompaniesBiosidus

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

ATC CodeL03AA10